Delivery Order SPE2DB22D1002-SPE2DB24FLGA8
Award Date
8/6/24
Potential Completion Date
8/7/24
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,854.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VERQUVO 5 MG TABLET 30S, a pharmaceutical product, and has an ultimate completion date of June 10, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. The contract was not designated with a set-aside requirement, indicating open...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,889.11 firm fixed-price delivery order is for the supply of 4565940358 - VERQUVO 5 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of September 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,887.52 Firm Fixed Price Delivery Order contract is for the supply of VERQUVO 2.5 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 6, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,684.71 firm fixed-price delivery order is for the supply of VERQUVO 2.5 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of December 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,113.47 delivery order contract is for the supply of VERQUVO 5 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance through March 4, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a larger $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,867.54 firm fixed-price delivery order is for the supply of VERQUVO 10 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of March 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,705.63, is for the delivery of the drug VERQUVO 10 MG TABLET 90S. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 28, 2024. The contract was awarded on October 25, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen, a for-profit organization,...
This federal contract award, valued at $2,870.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the drug product VERQUVO 5 MG TABLET 14S, with an ultimate completion date of February 24, 2025. The contract is a firm fixed-price arrangement and was not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order worth $3,041.52 by the Defense Logistics Agency (DLA) to provide VERQUVO 10 MG TABLET 30S, a pharmaceutical product, with a completion date of February 7, 2024. This order falls under Amerisourcebergen's existing indefinite delivery contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of VERQUVO 2.5 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price and a ceiling value of $1,004.82. The ultimate completion date is August 1, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has been awarded this contract to...